338840
Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor. It also develops immunoregulatory monoclonal antibodies, such as YBL-011 and AR062 for the treatment of solid cancers; AR166,… Read more
Market Cap & Net Worth: 338840 (338840)
338840 (KQ:338840) has a market capitalization of $346.11 Million (₩506.78 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #13966 globally and #383 in its home market, demonstrating a 47.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 338840's stock price ₩33900.00 by its total outstanding shares 14949181 (14.95 Million).
338840 Market Cap History: 2023 to 2026
338840's market capitalization history from 2023 to 2026. Data shows growth from $159.27 Million to $346.11 Million (53.23% CAGR).
338840 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 338840's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
338840's market cap is 0.01 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $159.27 Million | $3.48 Billion | -$20.87 Billion | 0.05x | N/A |
| 2024 | $78.51 Million | $5.76 Billion | -$6.44 Billion | 0.01x | N/A |
Competitor Companies of 338840 by Market Capitalization
Companies near 338840 in the global market cap rankings as of March 19, 2026.
Key companies related to 338840 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
338840 Historical Marketcap From 2023 to 2026
Between 2023 and today, 338840's market cap moved from $159.27 Million to $ 346.11 Million, with a yearly change of 53.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩346.11 Million | +48.03% |
| 2025 | ₩233.80 Million | +197.79% |
| 2024 | ₩78.51 Million | -50.71% |
| 2023 | ₩159.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 338840 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $346.11 Million USD |
| MoneyControl | $346.11 Million USD |
| MarketWatch | $346.11 Million USD |
| marketcap.company | $346.11 Million USD |
| Reuters | $346.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.